202 related articles for article (PubMed ID: 29101385)
1. Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody.
Liau B; Tan B; Teo G; Zhang P; Choo A; Rudd PM
Sci Rep; 2017 Nov; 7(1):14489. PubMed ID: 29101385
[TBL] [Abstract][Full Text] [Related]
2. Characterization of H type 1 and type 1
Choo M; Tan HL; Ding V; Castangia R; Belgacem O; Liau B; Hartley-Tassell L; Haslam SM; Dell A; Choo A
J Biol Chem; 2017 Apr; 292(15):6163-6176. PubMed ID: 28167527
[TBL] [Abstract][Full Text] [Related]
3. Porcine sperm bind to specific 6-sialylated biantennary glycans to form the oviduct reservoir.
Kadirvel G; Machado SA; Korneli C; Collins E; Miller P; Bess KN; Aoki K; Tiemeyer M; Bovin N; Miller DJ
Biol Reprod; 2012 Jun; 87(6):147. PubMed ID: 23115267
[TBL] [Abstract][Full Text] [Related]
4. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics.
Zhang X; Wang Y; Qian Y; Wu X; Zhang Z; Liu X; Zhao R; Zhou L; Ruan Y; Xu J; Liu H; Ren S; Xu C; Gu J
PLoS One; 2014; 9(2):e87978. PubMed ID: 24516574
[TBL] [Abstract][Full Text] [Related]
5. Structural Elucidation and Prognostic Relevance of 297-11A-Sulfated Glycans in Ovarian Carcinoma.
Inoue D; Hoshino H; Chen YY; Yamamoto M; Kogami A; Fukushima M; Khoo KH; Akama TO; Yoshida Y; Kobayashi M
Lab Invest; 2024 Jun; 104(6):102057. PubMed ID: 38582455
[TBL] [Abstract][Full Text] [Related]
6. History and future of shotgun glycomics.
Smith DF; Cummings RD; Song X
Biochem Soc Trans; 2019 Feb; 47(1):1-11. PubMed ID: 30626702
[TBL] [Abstract][Full Text] [Related]
7. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
Guo H; Abbott KL
Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
9. Acute-phase glycoprotein N-glycome of ovarian cancer patients analyzed by CE-LIF.
Weiz S; Wieczorek M; Schwedler C; Kaup M; Braicu EI; Sehouli J; Tauber R; Blanchard V
Electrophoresis; 2016 Jun; 37(11):1461-7. PubMed ID: 26763099
[TBL] [Abstract][Full Text] [Related]
10. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
11. Serum antibody screening by surface plasmon resonance using a natural glycan microarray.
de Boer AR; Hokke CH; Deelder AM; Wuhrer M
Glycoconj J; 2008 Jan; 25(1):75-84. PubMed ID: 18193481
[TBL] [Abstract][Full Text] [Related]
12. Identification of Antigenic Glycans from Schistosoma mansoni by Using a Shotgun Egg Glycan Microarray.
Mickum ML; Prasanphanich NS; Song X; Dorabawila N; Mandalasi M; Lasanajak Y; Luyai A; Secor WE; Wilkins PP; Van Die I; Smith DF; Nyame AK; Cummings RD; Rivera-Marrero CA
Infect Immun; 2016 May; 84(5):1371-1386. PubMed ID: 26883596
[TBL] [Abstract][Full Text] [Related]
13. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
14. Development of a Schistosoma mansoni shotgun O-glycan microarray and application to the discovery of new antigenic schistosome glycan motifs.
van Diepen A; van der Plas AJ; Kozak RP; Royle L; Dunne DW; Hokke CH
Int J Parasitol; 2015 Jun; 45(7):465-75. PubMed ID: 25819714
[TBL] [Abstract][Full Text] [Related]
15. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.
Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH
Mol Oncol; 2017 Nov; 11(11):1595-1615. PubMed ID: 28853212
[TBL] [Abstract][Full Text] [Related]
16. Shotgun glycomics: a microarray strategy for functional glycomics.
Song X; Lasanajak Y; Xia B; Heimburg-Molinaro J; Rhea JM; Ju H; Zhao C; Molinaro RJ; Cummings RD; Smith DF
Nat Methods; 2011 Jan; 8(1):85-90. PubMed ID: 21131969
[TBL] [Abstract][Full Text] [Related]
17. Use of glycan microarrays to explore specificity of glycan-binding proteins.
Smith DF; Song X; Cummings RD
Methods Enzymol; 2010; 480():417-44. PubMed ID: 20816220
[TBL] [Abstract][Full Text] [Related]
18. Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.
Pochechueva T; Chinarev A; Schoetzau A; Fedier A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V
PLoS One; 2016; 11(10):e0164230. PubMed ID: 27764122
[TBL] [Abstract][Full Text] [Related]
19. Glycan microarrays of fluorescently-tagged natural glycans.
Song X; Heimburg-Molinaro J; Smith DF; Cummings RD
Glycoconj J; 2015 Oct; 32(7):465-73. PubMed ID: 25877830
[TBL] [Abstract][Full Text] [Related]
20. Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics.
Li Z; Zhang Q; Ashline D; Zhu Y; Lasanajak Y; Chernova T; Reinhold V; Cummings RD; Wang PG; Ju T; Smith DF; Song X
Anal Chem; 2020 Aug; 92(15):10390-10401. PubMed ID: 32539345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
